×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
JAGX Stock Earnings: Jaguar Health Misses Revenue for Q4 2023
MSN
JAGX stock results show that Jaguar Health missed on revenue for the fourth quarter of 2023.More From InvestorPlace The #1 AI Investment Might Be This...
2 days ago
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Yahoo Finance
Jaguar Health, Inc. ... Jaguar family company Napo Pharmaceuticals focuses on developing and commercializing human prescription pharmaceuticals...
3 weeks ago
What Is Going on With Jaguar Health (JAGX) Stock Today?
InvestorPlace
Jaguar Health (JAGX) is holding off on a potential reverse stock split. The company hopes a new study will help create a market for its...
3 weeks ago
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu ...
WKRN News 2
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines...
3 days ago
Jaguar Health's Strategic Moves to Regain Nasdaq Compliance - TipRanks.com
Tipranks
Jaguar Animal Health (JAGX) has issued an announcement. Jaguar Health, Inc. stockholders approved all four proposals during a special...
3 weeks ago
Jaguar Health stock gains as reverse stock split cleared
Seeking Alpha
Jaguar Health (NASDAQ:JAGX) shares spiked on Wednesday after the antidiarrheal drug developer won shareholder approval to implement a...
3 weeks ago
Jaguar Health, Inc. | Nation and World | corsicanadailysun.com
Corsicana Daily Sun
Jaguar planning to begin commercial launch in Q3 2024 for Gelclair®, the company's third prescription product Oral mucositis,...
2 weeks ago
Jaguar Health balances ambitions for human and animal pharmaceuticals
Pharmaceutical Technology
After having completed a Phase III registrational trial investigating its treatment for diarrhoea related to cancer care called Mytesi (...
1 month ago
Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance
Yahoo Finance
SAN FRANCISCO, CA / ACCESSWIRE / February 23, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update...
2 months ago
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript
Yahoo Finance
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript April 1, 2024 Jaguar Health, Inc. isn't one of the 30 most popular stocks...
1 month ago